TCV

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Sep 10, 2026

TCV is a global technology growth-equity investor, with equity investments ranging from $10 million to $500 million and flexibility around transaction structure.

Its approach is to maintain a concentrated portfolio and commit substantial time and capital to a selected group of companies. It remains involved as businesses expand their products and enter additional geographies.

The firm’s offices in Menlo Park, New York and London support a portfolio spanning five continents. Its financing model is suited to growth-stage technology businesses undertaking a significant expansion rather than only the first product-development round.

Sources
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$50M
1 disclosed · full round size, not this investor’s share

By stage

Series C+1

By primary sector

Healthtech1

By country

United States1

Rounds

1 in this selection
Archy

Cloud software combines dental practice operations and clinical tools with AI agents for routine administrative work.

$50MSeries C
Participant